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Outpatient no-shows are going to be a regular occurrence for any nuclear medicine 
department. Hospitals lose thousands of dollars each year from non-attendance. 
Determining the overall monetary impact of the no-shows and uncovering which 
procedures contribute most in terms total no-shows and total financial impact is a first 
step in alleviating some of this loss.  
Method: From a Nuclear Medicine children’s hospital, six months of data were collected 
retrospectively from December 2012 through May 2013. This included: procedure, 
current procedural terminology codes, total number of scans, total number of no-shows, 
as well as total hospital cost, and total revenue lost. The percentage for each procedure 
contributing to the total financial impact was calculated by dividing the cost for each 
procedure by the total loss in revenue. This was done for the total hospital cost 
(radiopharmaceuticals) and the total revenue loss (technical component).    
Results: From December 2012 through May 2013 the financial impact for this nuclear 
medicine department was $17,512.32. The procedures contributing to the most hospital 
cost were renal dynamic imaging, renal morphology imaging, and gastric emptying, 
resulting in 54%, 19.2%, 13.4% respectively. The procedures contributing to the most 
revenue loss were gastric emptying, renal dynamic imaging, and hepatobiliary imaging, 
resulting in 30.7%, 17.0%, and 13.4% respectively.  
Conclusion: Outpatient no-shows are going to be a regular occurrence for any nuclear 
medicine department, but losing money does not have to be. Nuclear medicine 
departments need to discover ways of eliminating no-shows and identify which 
procedures contribute to the most financial impact. This is imperative in reducing the 
amount of revenue lost from wasted radiopharmaceuticals, technologist’s time, and the 
technical components in a department.     
